Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biovail Corporation
Biovail Announces Dismissal of Securities Litigation
May 30th, 2009
Biovail Corporation (NYSE:BVF)(TSX:BVF) announced that, on May 8, 2009, the United States District Court for the Southern District of New York issued a decision dismissing with prejudice a purported securities fraud lawsuit against Biovail and several of its present and former officers and directors (Fort Worth Employees’ Retirement Fund v. Biovail Corporation, et al., No. 08 Civ. 8592). The complaint related to statements alleged to have been made by the Company and by certain officers in respect of Aplenzin™ (bupropion hydrobromide tablets) during the product’s U.S. regulatory approval process. In its decision dismissing the plaintiff’s amended complaint, the court...
Source: Law & Health Weekly (2009-05-30)
|
